Strategic Vision and Infarmed 2026 Priorities f...

By João L. Carapinha

February 12, 2026

Infarmed 2026 Priorities Take Shape in Leadership Summit Infarmed 2026 priorities crystallized during the Executive Board's February 11, 2026, session with unit directors, led...
AstraZeneca Financial Results: Strong Revenue Growth and Pipeline Expansion i...
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes
European Pharma Competitiveness: A Cornerstone for EU Economic Resilience
National HealthTech Access: Transforming NHS Adoption and Equity
Tislelizumab NSCLC Inclusion Recommended for Dutch Health Package
Healthcare Innovation Trends Shaping the Future: Insights from the J.P. Morga...
Novo Nordisk Growth Projections: Insights on 2025 Performance and 2026 Outlook
AI Healthcare Costs: Navigating Financial Hurdles in Technology Integration
Ozempic Public Funding Approval in Portugal: Key Insights and Implications
Surge in Obesity Intervention Costs in the Netherlands
HPV Vaccination Benefits Portugal: A Cost-Benefit Analysis of Expansion Effects
Expansion of Generic Medicines Authorization in Portugal